Skip to main content
Article
Clonality of borderline and serous carcinoma of the ovary: Molecular studies identify a monoclonal origin for primary tumors and their implants
All Scholarly Works
  • Reva Ricketts-Loriaux, MD, Baystate Health
  • Christopher Otis, MD, Baystate Health
Document Type
Presentations, Research
Publication Date
2-1-2006
Citation Information
Ricketts R, Otis C, Sobel M, Merino M. Clonality of borderline and serous carcinoma of the ovary: Molecular studies identify a monoclonal origin for primary tumors and their implants. United States and Canadian Academy of Pathology 95th Annual Meeting. Atlanta, GA. Feb 11-Feb 17, 2006.